Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
Authors
Keywords
-
Journal
EMBO Molecular Medicine
Volume 13, Issue 8, Pages -
Publisher
EMBO
Online
2021-06-25
DOI
10.15252/emmm.202114122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death
- (2021) Wenjing Chen et al. BIOLOGICAL PROCEDURES ONLINE
- Oral ivermectin for a scabies outbreak in a long‐term–care facility: Potential value in preventing COVID‐19 and associated mortality?
- (2021) C. Bernigaud et al. BRITISH JOURNAL OF DERMATOLOGY
- Ivermectin as a potential drug for treatment of COVID-19: an in-sync review with clinical and computational attributes
- (2021) Harpinder Kaur et al. Pharmacological Reports
- Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity
- (2021) Daisy A. Hoagland et al. IMMUNITY
- Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
- (2021) Pierre Kory et al. AMERICAN JOURNAL OF THERAPEUTICS
- COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters
- (2021) Guilherme Dias de Melo et al. Science Translational Medicine
- Ivermectin reduces in vivo coronavirus infection in a mouse experimental model
- (2021) A. P. Arévalo et al. Scientific Reports
- Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations
- (2021) Edward J. Calabrese et al. RADIOTHERAPY AND ONCOLOGY
- Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency
- (2020) Carlos Chaccour et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The Glycine Receptor Allosteric Ligands Library (GRALL)
- (2020) Adrien H Cerdan et al. BIOINFORMATICS
- Smell and taste dysfunction in patients with COVID-19
- (2020) Michael S Xydakis et al. LANCET INFECTIOUS DISEASES
- Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
- (2020) Sin Fun Sia et al. NATURE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens
- (2020) Tao Suo et al. Emerging Microbes & Infections
- Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
- (2020) Jian-Min Jin et al. Frontiers in Public Health
- Novel insights on the pulmonary vascular consequences of COVID-19
- (2020) François Potus et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Characterization of the Inflammatory Response to Severe COVID-19 Illness
- (2020) Oliver J McElvaney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
- (2020) Mike Bray et al. ANTIVIRAL RESEARCH
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment
- (2020) Jing Sun et al. CELL
- Anosmia in COVID-19: Mechanisms and Significance
- (2020) Albert Y Han et al. CHEMICAL SENSES
- Managing Hyperglycemia in the COVID-19 Inflammatory Storm
- (2020) Roma Gianchandani et al. DIABETES
- Nicotine and the nicotinic cholinergic system in COVID‐19
- (2020) Yousef Tizabi et al. FEBS Journal
- Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor
- (2020) Xiaopeng Hu et al. Future Virology
- Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
- (2020) Fatemeh Heidary et al. JOURNAL OF ANTIBIOTICS
- Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis
- (2020) Roberto Rossotti et al. JOURNAL OF INFECTION
- COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?
- (2020) Antonio Oliviero et al. NEUROSCIENTIST
- Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study
- (2020) Chenghao Qiu et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Targeting the NO‐cGMP‐PDE5 pathway in COVID‐19 infection. The DEDALO project
- (2020) Andrea M. Isidori et al. Andrology
- Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
- (2020) Sonu Bhaskar et al. Frontiers in Immunology
- Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade
- (2020) Ashmita Dey et al. BRIEFINGS IN BIOINFORMATICS
- Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study)
- (2020) Juliana Cepelowicz Rajter et al. CHEST
- Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment
- (2020) Na Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
- (2020) Si Zhang et al. Journal of Hematology & Oncology
- Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing
- (2020) Brian Jermain et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Animal models for COVID-19
- (2020) César Muñoz-Fontela et al. NATURE
- Sex differences in immune responses that underlie COVID-19 disease outcomes
- (2020) Takehiro Takahashi et al. NATURE
- Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19
- (2020) Francesco De Virgiliis et al. Nature Reviews Neurology
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Sustained Stimulation of β2AR Inhibits Insulin Signaling in H9C2 Cardiomyoblast Cells Through the PKA-Dependent Signaling Pathway
- (2020) Jinli Pei et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches
- (2020) Pedro N. Batalha et al. BIOORGANIC CHEMISTRY
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- (2020) Ryan M. Samuel et al. Cell Stem Cell
- Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg
- (2020) Imran Hasanoglu et al. INFECTION
- STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
- (2020) Robbert Boudewijns et al. Nature Communications
- Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
- (2020) Megan L. Stanifer et al. Frontiers in Immunology
- Activation of Alpha-7 Nicotinic Acetylcholine Receptors (α7nAchR) Promotes the Protective Autophagy in LPS-Induced Acute Lung Injury (ALI) In Vitro and In Vivo
- (2019) Xin Zhao et al. INFLAMMATION
- Wnt signaling mediates TLR pathway and promote unrestrained adipogenesis and metaflammation: Therapeutic targets for obesity and type 2 diabetes
- (2019) Khurram Aamir et al. PHARMACOLOGICAL RESEARCH
- Blockade of glutamate receptor ameliorates lipopolysaccharide-induced sepsis through regulation of neuropeptides
- (2018) Zhai Zhe et al. BIOSCIENCE REPORTS
- IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission
- (2018) Jonas Klinkhammer et al. eLife
- PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
- (2018) Huaiyu Mi et al. NUCLEIC ACIDS RESEARCH
- Sex and sex steroids impact influenza pathogenesis across the life course
- (2018) Landon G. vom Steeg et al. Seminars in Immunopathology
- Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
- (2017) Ioanna E. Galani et al. IMMUNITY
- All the “RAGE” in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses
- (2017) Elizabeth A. Oczypok et al. Paediatric Respiratory Reviews
- Ivermectin – Old Drug, New Tricks?
- (2017) Roz Laing et al. TRENDS IN PARASITOLOGY
- Nicotinic alpha 7 receptor expression and modulation of the lung epithelial response to lipopolysaccharide
- (2017) Lorise C. Gahring et al. PLoS One
- MultiQC: summarize analysis results for multiple tools and samples in a single report
- (2016) Philip Ewels et al. BIOINFORMATICS
- Sex-dependent effects of nicotine on the developing brain
- (2016) Sarah J. Cross et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
- (2016) Verena Katharina Raker et al. Frontiers in Immunology
- SARTools: A DESeq2- and EdgeR-Based R Pipeline for Comprehensive Differential Analysis of RNA-Seq Data
- (2016) Hugo Varet et al. PLoS One
- The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer
- (2014) A. Melotti et al. EMBO Molecular Medicine
- The GOA database: Gene Ontology annotation updates for 2015
- (2014) Rachael P. Huntley et al. NUCLEIC ACIDS RESEARCH
- BioServices: a common Python package to access biological Web Services programmatically
- (2013) Thomas Cokelaer et al. BIOINFORMATICS
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
- (2013) Edward Y Chen et al. BMC BIOINFORMATICS
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Snakemake--a scalable bioinformatics workflow engine
- (2012) J. Koster et al. BIOINFORMATICS
- Early Activation of Microglia Triggers Long-Lasting Impairment of Adult Neurogenesis in the Olfactory Bulb
- (2012) F. Lazarini et al. JOURNAL OF NEUROSCIENCE
- The vagus nerve and the inflammatory reflex—linking immunity and metabolism
- (2012) Valentin A. Pavlov et al. Nature Reviews Endocrinology
- Principles of activation and permeation in an anion-selective Cys-loop receptor
- (2011) Ryan E. Hibbs et al. NATURE
- Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells
- (2011) Tamaki Okabayashi et al. VIRUS RESEARCH
- Effects of Ivermectin on Blood-Feeding Phlebotomus papatasi, and the Promastigote Stage of Leishmania major
- (2010) Hanafi A. Hanafi et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Glycine and glycine receptor signalling in non-neuronal cells
- (2009) Jimmy Van den Eynden Frontiers in Molecular Neuroscience
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started